LifeX Accelerator Program for Early-Stage Ventures in United States

About the Program

• Specialized Content
  • Specifically tailored for early-stage healthcare and life science spin outs
  • Intentional focus on preparing an investable commercialization plan
• Hands-On Support
  • Dedicated mentor with company specific expertise as a guide through the program
  • Dedicated intern providing project support
  • 1 on 1 office hours support with experts
• Access To a Broad & Diverse Network
  • Program speakers and contributors include 40+ experts across multiple institutions, geographies, and industries
  • Promotion of participating companies to LifeX’s broader network

Expected Outcomes

• Successes from past cohorts include:
  • Funding
    • Follow on funding through SBIRs, PHDA, and other private investment
  • Acceptance
    • Acceptance into subsequent accelerator programs including AlphaLab Health, IndieBio, Creative Destruction Labs
  • Partnerships
    • Continued partnerships with regulatory, reimbursement, data privacy, & strategy services introduced through LifeX
  • Talent Acquisition
    • Talent acquisition of team members introduced through Accelerator programming

Eligibility Criteria

• Committed to commercializing technology in the pharma, medical device, diagnostic or digital health space
• Have a proof of concept or validated the underlying scientific feasibility
• On the path to securing or licensing the necessary IP rights to commercialize
• Preferentially have already completed some basic business programming and customer discovery
• Have a founder committed to joining the company in an operational capacity in the future
• Program does not require a legal business entity be formed, but anticipate so in the near future
• At least one member of the founding team is able to spend a minimum of 6-8 hours per week participating in programming and dedicated work efforts for the duration of the accelerator program.

For more information, visit LifeX.